APP and Alzheimer disease: Furthermore, studies on APP/PS1 mice at different ages indicate that Mertk mRNA levels increase initially and then decrease 56, suggesting a complex role of Mertk in AD and highlighting the importance of exploring its involvement in the early stage of the disease.